HOME >> MEDICINE >> NEWS
HIV vaccine trial breaks ground for future research

The results of the world's first phase 3 HIV vaccine efficacy trial are reported in the March 1 issue of The Journal of Infectious Diseases, now available online. Although the vaccine was ineffective in preventing HIV infection, the trial represents a landmark in the fight against HIV and offers the scientific community a foundation on which to build future trials.

The multi-centered trial, conducted in the United States and the Netherlands and completed in 2003, is described in two papers by the rgp120 HIV Vaccine Study Group, and Peter B. Gilbert and colleagues, which address the vaccine efficacy results and the immunologic responses of the study participants.

The vaccine, produced by VaxGen, was a recombinant construct of the HIV envelope glycoprotein, similar to the type of vaccine used to develop a vaccine for hepatitis B. The vaccine was tested in a double-blind, randomized study of healthy participants who did not use intravenous drugs. The volunteers were men who have sex with men or women at high risk for heterosexual transmission. The vaccine and placebo were given by injection seven times over 30 months and the participants were assessed for risk. At each visit the participants were tested for HIV infection, and for those who were positive, HIV-1 plasma RNA load and CD4 cell counts were monitored on a regular basis for 24 months after the initial diagnosis.

Of the 5,417 volunteers who were enrolled, 368 became infected during the study. The vaccine was found not to be effective in preventing HIV infection; infection rates among those who were given the vaccine and those who were given placebo were 6.7 percent and 7.0 percent, respectively. Of those who became infected during the study, pre-treatment viral loads were similar in the placebo and vaccine groups over their follow-up visits.

During analysis of various subgroups of the study population, a higher, though statistically insignificant, vaccine efficacy was found in th
'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
3-Feb-2005


Page: 1 2

Related medicine news :

1. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
2. NIAID initiates trial of experimental avian flu vaccine
3. Study finds majority of women willing to accept cervical cancer vaccine for self and children
4. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
5. Earlier use of prostate cancer vaccines urged by Hopkins scientists
6. Researchers close in on breast cancer vaccine
7. EuroVacc 02 HIV vaccine trial begins in February 2005
8. Varicella vaccine effective on chicken pox; Impact on herpes zoster unclear
9. Pathogen-mimicking vaccine as strategy for cancer therapy
10. First US kidney cancer vaccine trial underway at Columbia
11. NIAID begins enrolling volunteers for novel HIV vaccine study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... ... February 13, 2020 , ... Charles Seal-Villafranca, DHA(c), ... in Phoenix, AZ announced today his re-election as the President of the Arizona ... Managers (NCIA). , As President of the State Board, Villafranca acts as ...
(Date:2/11/2020)... , ... February 11, 2020 , ... ... services and solutions, today announced its move to a new, significantly larger business ... customer base alongside significant expansion in the development of digital technology platforms. , ...
(Date:2/10/2020)... (PRWEB) , ... February 11, 2020 , ... R3 Medical ... for March 11-12th, 2020 in Las Vegas. The training consists of thread lift placement ... 988-6343 to register. , PDO thread lifts represent an excellent alternative currently for nonoperative ...
(Date:2/10/2020)... ... 2020 , ... How About That’s Sweet Trail Mix is a blend of keto approved nuts, ... of fat, 4 grams of protein and 3 grams of net carbs with zero added ... salt, making it the cleanest keto trail mix on the market. , The trail mix ...
(Date:2/10/2020)... ... February 10, 2020 , ... Real Food Blends , makers of 100% ... real food revolution in the medical community, is proud to announce the recipient of ... tube community each year during Feeding Tube Awareness Week . Feeding Tube Awareness ...
Breaking Medicine News(10 mins):
(Date:2/13/2020)... ... February 13, 2020 , ... Worldwide Business with ... Skincare Founder and Leukemia Lymphoma Society's Woman of The Year Candidate Carmen ... , Latina-owned and founded in San Francisco, Borbón Skincare is a premium skincare ...
(Date:2/11/2020)... ... February 11, 2020 , ... Terry Moore, a renowned business leader and popular ... Homeolux ™ and the company’s Beacon40 ™ product line. Singularly focused on ... technology company that designs wellness products based on cutting-edge scientific research. With the ...
(Date:2/11/2020)... ... February 11, 2020 , ... Acuity Eye Group ... run by Dr. Daniel Coden, Dr. Arthur Perry, and Dr. Steven Pratt to its ... patients in the La Jolla and San Diego community for over 40 years and ...
Breaking Medicine Technology:
Cached News: